CN108250196A - (哌嗪-1-基)-1氢-咪唑并杂芳环化合物的制备方法 - Google Patents
(哌嗪-1-基)-1氢-咪唑并杂芳环化合物的制备方法 Download PDFInfo
- Publication number
- CN108250196A CN108250196A CN201611245479.0A CN201611245479A CN108250196A CN 108250196 A CN108250196 A CN 108250196A CN 201611245479 A CN201611245479 A CN 201611245479A CN 108250196 A CN108250196 A CN 108250196A
- Authority
- CN
- China
- Prior art keywords
- preparation
- formula
- acid
- hydrogen
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611245479.0A CN108250196B (zh) | 2016-12-29 | 2016-12-29 | (哌嗪-1-基)-1氢-咪唑并杂芳环化合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611245479.0A CN108250196B (zh) | 2016-12-29 | 2016-12-29 | (哌嗪-1-基)-1氢-咪唑并杂芳环化合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108250196A true CN108250196A (zh) | 2018-07-06 |
CN108250196B CN108250196B (zh) | 2022-12-30 |
Family
ID=62719108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611245479.0A Active CN108250196B (zh) | 2016-12-29 | 2016-12-29 | (哌嗪-1-基)-1氢-咪唑并杂芳环化合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108250196B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT323166B (de) * | 1970-12-21 | 1975-06-25 | Lilly Co Eli | Verfahren zur herstellung von neuen 1-substituierten 2-(1,1-difluoralkyl)-1h-imidazo(4,5-b)pyridinver bindungen |
WO2011107530A2 (en) * | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
CN102659778A (zh) * | 2012-03-22 | 2012-09-12 | 盛世泰科生物医药技术(苏州)有限公司 | 6-氨基-2-甲基-3H-咪唑并[4,5-b]吡啶的合成新工艺 |
CN106146492A (zh) * | 2015-04-17 | 2016-11-23 | 上海汇伦生命科技有限公司 | 杂环并咪唑类化合物、其药物组合物及其制备方法和用途 |
-
2016
- 2016-12-29 CN CN201611245479.0A patent/CN108250196B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT323166B (de) * | 1970-12-21 | 1975-06-25 | Lilly Co Eli | Verfahren zur herstellung von neuen 1-substituierten 2-(1,1-difluoralkyl)-1h-imidazo(4,5-b)pyridinver bindungen |
WO2011107530A2 (en) * | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
CN102659778A (zh) * | 2012-03-22 | 2012-09-12 | 盛世泰科生物医药技术(苏州)有限公司 | 6-氨基-2-甲基-3H-咪唑并[4,5-b]吡啶的合成新工艺 |
CN106146492A (zh) * | 2015-04-17 | 2016-11-23 | 上海汇伦生命科技有限公司 | 杂环并咪唑类化合物、其药物组合物及其制备方法和用途 |
Non-Patent Citations (3)
Title |
---|
DANIEL RAMSBECK: "Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold", 《JOURNAL OF MEDICINAL CHEMISTRY》 * |
LIU, Z,ET AL: "A Facile One-Pot Synthesis of Benzimidazoles from 2-Nitroanilines by Reductive", 《HETEROCYCLES》 * |
程正: "苯并咪唑类化合物催化合成的研究进展", 《有机化学》 * |
Also Published As
Publication number | Publication date |
---|---|
CN108250196B (zh) | 2022-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0572437B1 (en) | 2,4-diaminoquinazolines derivatives for enhancing antitumor activity | |
CN106220641B (zh) | 含愈创兰烃薁结构的吲哚螺环类化合物及其制备方法与应用 | |
CA2558051C (en) | Palladium catalyzed indolization of 2-bromo or chloroanilines | |
AU2010212560B2 (en) | Derivatives of azaindoles as inhibitors of protein kinases Abl and Src | |
CN107383004B (zh) | 2-氨基咪唑并吡啶类衍生物及制备和应用 | |
EP1436283B1 (en) | Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof | |
Zhao et al. | Pyrrolo [2, 3-b] pyridine derivatives as potent Bruton’s tyrosine kinase inhibitors | |
KR102580179B1 (ko) | Mek억제제로서의 쿠마린 고리계 화합물 및 이의 용도 | |
CN114524772A (zh) | 一种含杂环串联类化合物及其制备方法与应用 | |
CN107739368B (zh) | N-取代-5-((4-取代嘧啶-2-基)氨基)吲哚类衍生物及其制备方法和用途 | |
CN108250196A (zh) | (哌嗪-1-基)-1氢-咪唑并杂芳环化合物的制备方法 | |
CN110526913B (zh) | 一种抗凝药物阿哌沙班相关物质的制备方法 | |
CN101544642A (zh) | 4-蝶啶氨类化合物及其制备和用途 | |
CN114835640B (zh) | 成纤维细胞生长因子受体抑制剂、制备方法及应用 | |
EP4393921A1 (en) | Nalidinone compound as fgfr4 inhibitor and use thereof | |
CN102432553B (zh) | 喹唑啉衍生物的制备方法及其中间体 | |
CN110305128B (zh) | 5-氨基苯并[b][1,8]萘啶类化合物的制备方法和应用 | |
CN104592114A (zh) | 取代喹啉类组蛋白去乙酰化酶抑制剂及制备方法和应用 | |
CN105153048B (zh) | 一种2,4‑喹唑啉二酮类化合物的制备方法 | |
CN110862396B (zh) | 一种吡咯并[3,4-c]咔唑-1,3(2H,6H)-二酮类化合物的合成方法 | |
CN110194741B (zh) | 4-苯甲酰哌嗪-3-硝基-1,8-萘酰亚胺衍生物及其制备方法和应用 | |
CN109369653B (zh) | 哒嗪[6,1-b]并喹唑啉酮衍生物及其制备方法和应用 | |
CN110078706B (zh) | 一种伊马替尼衍生物及其制备方法和用途 | |
CN108358841B (zh) | 一类4-((2-取代喹啉-4-基)氨基)苯甲酰肼类衍生物及其制备方法与应用 | |
CN106496118B (zh) | 一种喹啉类烯胺酮化合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Room 650-10, building 2, 351 GuoShouJing Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai, 201203 Applicant after: Shanghai Hui Bio Technology Co.,Ltd. Applicant after: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. Address before: Room 650-10, Building No. 2, 351 Guoshoujing Road, Pudong New Area Free Trade Pilot Area, Shanghai, 201203 Applicant before: SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY Co.,Ltd. Applicant before: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 200241 floor 10, building 5, No. 525, Yuanjiang Road, Minhang District, Shanghai Applicant after: Shanghai Huilun Pharmaceutical Co.,Ltd. Applicant after: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. Address before: Room 650-10, building 2, No. 351, GuoShouJing Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai, 201203 Applicant before: Shanghai Hui Bio Technology Co.,Ltd. Applicant before: SHANGHAI HUILUN JIANGSU PHARMACEUTICAL Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |